Acetone → N-((1'-benzyl-1-(5-ethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)spiro[indoline-3,4'-piperidine]-4-yl)methyl)propan-2-amine

HRID 529146노트

반응식

HRID 529146 반응식
F[C:2](F)(F)[C:3](O)=O.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O.[CH2:22]([N:29]1[CH2:34][CH2:33][C:32]2([C:42]3[C:37](=[CH:38][CH:39]=[CH:40][C:41]=3[CH2:43][NH2:44])[N:36]([C:45]3[C:46]4[CH:53](CC)[CH2:52][CH2:51][C:47]=4[N:48]=[CH:49][N:50]=3)[CH2:35]2)[CH2:31][CH2:30]1)[C:23]1[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1.[CH3:56][C:57]([CH3:59])=O.[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+].C(N)(C)C>ClCCCl>[CH2:22]([N:29]1[CH2:34][CH2:33][C:32]2([C:42]3[C:37](=[CH:38][CH:39]=[CH:40][C:41]=3[CH2:43][NH:44][CH:57]([CH3:59])[CH3:56])[N:36]([C:45]3[C:46]4[CH:53]([CH2:2][CH3:3])[CH2:52][CH2:51][C:47]=4[N:48]=[CH:49][N:50]=3)[CH2:35]2)[CH2:31][CH2:30]1)[C:23]1[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1

참가 물질

6

반응물 4

HCID 180AcetoneHCID 6363IsopropylamineHCID 5049666Sodium triacetoxyborohydrideHCID 86651813(1'-benzyl-1-(5-ethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)spiro[indoline-3,4'-piperidine]-4-yl)methanamine tris(2,2,2-trifluoroacetate)

생성물 1

HCID 69811460N-((1'-benzyl-1-(5-ethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)spiro[indoline-3,4'-piperidine]-4-yl)methyl)propan-2-amine수율 18%

시약·촉매·용매 1

HCID 111,2-Dichloroethane용매

실험 절차

(1′-Benzyl-1-(5-ethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)spiro[indoline-3,4′-piperidine]-4-yl)methanamine tris(2,2,2-trifluoroacetate) (606 mg, 0.762 mmol) was stirred in a solution of acetone (0.280 mL, 3.81 mmol) and DCE (5 mL) for 15 minutes. NaBH(OAc)3 (323 mg, 1.52 mmol) was added in one portion and resulted in vigorous evolution of gas. After 1 hour at room temperature, LCMS suggested complete conversion to the desired isopropylamine. The reaction was concentrated and partitioned between EtOAc and 10% aqueous K2CO3. The organic was washed with brine, dried over Na2SO4 and concentrated to a crude residue. The racemic crude was purified by silica gel chromatography (gradient: 5-100% (80 DCM: 19 MeOH: 1 NH4OH)/DCM). Purification provided N-((1′-benzyl-1-(5-ethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)spiro[indoline-3,4′-piperidine]-4-yl)methyl)propan-2-amine (68 mg, 0.137 mmol, 18.0% yield) as an oil. 1H NMR (CDCl3, 400 MHz) δ 8.62 (s, 1H), 7.27-7.33 (m, 5H), 7.24 (m, 1H), 7.18 (t, 1H), 6.96 (d, 1H), 3.95 (m, 4H), 3.54 (s, 2H), 3.27 (m, 1H), 2.84-2.99 (m, 5H), 2.63 (dt, 1H), 2.03-2.31 (m, 4H), 1.86 (m, 1H), 1.70 (dd, 2H), 1.42 (m, 2H), 1.15-1.119 (m, 7H), 0.78 (t, 3H). MS (APCI+) [M+H]: 496.3. Separation of isomers was conducted by preparative HPLC using a Chiralpak AD-H column (4.6×100 mm). The compound was eluted with 25% methanol/water (0.1% TEA additive) at 3 mL/min and 120 bars.

후처리

  1. customresulted in vigorous evolution of gas
  2. concentrationThe reaction was concentrated
  3. custompartitioned between EtOAc and 10% aqueous K2CO3
  4. washThe organic was washed with brine
  5. dry with materialdried over Na2SO4
  6. concentrationconcentrated to a crude residue
  7. customThe racemic crude was purified by silica gel chromatography (gradient: 5-100% (80 DCM: 19 MeOH: 1 NH4OH)/DCM)
  8. customPurification

출처 및 근거

ORD 기록
ord-ed62a519a65e485f80d3798e0c9fdd89
출처 데이터셋
uspto-grants-2016_05
특허 번호
US09346805B2

반응 노트

불러오는 중…